Such improvement promotes lipogenesis in fat (recall that IGF-1 could maintain cytokine homeostasisanti-inflammatory effects-, and thus protection from mild inflammation as a consequence of obesity)
On the other hand, the diabetic weight loss was perhaps better than expected
Xiong, B., Jha, V., Min, J
External resources Efficacy and safety of retatrutide: systematic review and meta-analysis (PMC) Triple hormone receptor agonist retatrutide for obesity: Phase 2 trial (NEJM) Tesamorelin clinical pharmacology and safety (NCBI LiverTox) Safety and metabolic effects of tesamorelin in type 2 diabetes (PMC) Tesamorelin prescribing information and side effects (Mayo Clinic) Retatrutide for metabolic dysfunction-associated steatotic liver disease (Nature Medicine) For researchers serious about optimizing their peptide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
One analysis determined that participants who stopped taking GLP1-drugs had regained about two-thirds of their previous weight loss after one year
It is an effective weight loss agent with studies observing 6.68.6 kg weight loss over 12 months [9]